Dx Deals: Collaboration Takes Psoriasis Testing to New Level
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
Both companies have made recent moves to diversify further.
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.